📊 SI Key Takeaways
Is Shoulder Innovations, Inc.. (SI) a Good Investment?
Strong revenue growth (49.6% YoY) and exceptional gross margins (77.7%) indicate product-market fit in a surgical instruments niche, but substantial operating losses (-53.7% margin) and negative operating cash flow (-12.4M) with only 11.5M cash create significant execution risk. Company must reach profitability before capital runway exhaustion.
Shoulder Innovations, Inc.. Key Strengths (SI)
- Strong revenue growth of 49.6% YoY demonstrates robust market demand
- Exceptional gross margins of 77.7% indicate competitive product pricing power and efficient manufacturing
- Healthy balance sheet with low leverage (0.11x Debt/Equity) and excellent liquidity (11.81x current ratio)
SI Stock Risks: Shoulder Innovations, Inc.. Investment Risks
- Negative operating cash flow (-12.4M) and limited cash runway of ~1 year at current burn rate
- Operating losses of -53.7% margin despite strong revenue growth indicates unsustainable unit economics
- May require dilutive capital raise to fund continued operations, pressuring shareholder value
Key Metrics to Watch
- Operating cash flow trend and progress toward positive FCF generation
- Operating expense ratio reduction and path to break-even profitability
- Revenue growth sustainability and gross margin consistency under scaling
Shoulder Innovations, Inc.. (SI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 11.81x current ratio provides a solid financial cushion.
SI Profit Margin, ROE & Profitability Analysis
SI vs Healthcare Sector: How Shoulder Innovations, Inc.. Compares
How Shoulder Innovations, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Shoulder Innovations, Inc.. Stock Overvalued? SI Valuation Analysis 2026
Based on fundamental analysis, Shoulder Innovations, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Shoulder Innovations, Inc.. Balance Sheet: SI Debt, Cash & Liquidity
SI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Shoulder Innovations, Inc..'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-242.04 indicates the company is currently unprofitable.
SI Revenue Growth, EPS Growth & YoY Performance
SI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $10.1M | -$4.7M | $-0.41 |
| Q3 2025 | $7.5M | -$3.6M | $-0.64 |
| Q2 2025 | $8.3M | -$3.6M | $-72.74 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Shoulder Innovations, Inc.. Dividends, Buybacks & Capital Allocation
SI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Shoulder Innovations, Inc.. (CIK: 0001699350)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SI
What is the AI rating for SI?
Shoulder Innovations, Inc.. (SI) has an AI grade of B with 65% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SI's key strengths?
Claude: Strong revenue growth of 49.6% YoY demonstrates robust market demand. Exceptional gross margins of 77.7% indicate competitive product pricing power and efficient manufacturing.
What are the risks of investing in SI?
Claude: Negative operating cash flow (-12.4M) and limited cash runway of ~1 year at current burn rate. Operating losses of -53.7% margin despite strong revenue growth indicates unsustainable unit economics.
What is SI's revenue and growth?
Shoulder Innovations, Inc.. reported revenue of $16.7M.
Does SI pay dividends?
Shoulder Innovations, Inc.. does not currently pay dividends.
Where can I find SI SEC filings?
Official SEC filings for Shoulder Innovations, Inc.. (CIK: 0001699350) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SI's EPS?
Shoulder Innovations, Inc.. has a diluted EPS of $-0.41.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SI's fundamental grade?
Based on our AI fundamental analysis in May 2026, Shoulder Innovations, Inc.. has a B grade with 65% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SI stock overvalued or undervalued?
Valuation metrics for SI: ROE of -6.3% (sector avg: 15%), net margin of -50.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is SI's AI grade for 2026?
Our dual AI analysis gives Shoulder Innovations, Inc.. a combined B grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SI's free cash flow?
Shoulder Innovations, Inc..'s operating cash flow is $-12.4M, with capital expenditures of $2.7M. FCF margin is -90.3%.
How does SI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -50.1% (avg: 12%), ROE -6.3% (avg: 15%), current ratio 11.81 (avg: 2).